Global Osteoarthritis and Osteoarthritis Pain Market Spotlight 2021: Clinical Trial Activity is Dominated by Completed Trials with Pfizer having the Most at 124 Trials
June 10, 2021 06:38 ET
|
Research and Markets
Dublin, June 10, 2021 (GLOBE NEWSWIRE) -- The "Market Spotlight: Osteoarthritis and Osteoarthritis Pain" report has been added to ResearchAndMarkets.com's offering. This Market Spotlight report...
TLC Announces Full Patient Enrollment in EXCELLENCE Trial of TLC599 for Osteoarthritis Pain
December 28, 2020 04:00 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Dec. 28, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
TLC Announces Positive End-of-Phase II Meeting with FDA for TLC599 in Knee Osteoarthritis
April 15, 2019 05:00 ET
|
TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, April 15, 2019 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company dedicated to the development and...